Literature DB >> 17660379

Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems.

Anna M Lundberg1, Stefan K Drexler, Claudia Monaco, Lynn M Williams, Sandra M Sacre, Marc Feldmann, Brian M Foxwell.   

Abstract

TLR3 recognizes double-stranded RNA, a product associated with viral infections. Many details of TLR3-induced mechanisms have emerged from gene-targeted mice or inhibition studies in transformed cell lines. However, the pathways activated in human immune cells or cells from disease tissue are less well understood. We have investigated TLR3-induced mechanisms of human primary cells of the innate immune system, including dendritic cells (DCs), macrophages (MØs), endothelial cells (ECs), and synovial fibroblasts isolated from rheumatoid arthritis joint tissue (RA-SFs). Here, we report that while these cells all express TLR3, they differ substantially in their response to TLR3 stimulation. The key antiviral response chemokine IP-10 was produced by all cell types, while DCs and MØs failed to produce the proinflammatory cytokines TNFalpha and IL-6. Unexpectedly, TNFalpha was found secreted by TLR3-stimulated RA-SF. Furthermore, TLR3 stimulation did not activate NFkappaB, MAPKs, or IRF-3 in DCs and MØs, but was able to do so in ECs and RA-SF. These findings were specific for human cells, thereby revealing a complexity not previously expected. This is the first report of such cell type- and species-specific response for any TLR stimulation and helps to explain important difficulties in correlating murine models of inflammatory diseases and human inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660379     DOI: 10.1182/blood-2007-02-072934

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  64 in total

1.  Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses.

Authors:  Suzanne L Tomchuck; Kevin J Zwezdaryk; Seth B Coffelt; Ruth S Waterman; Elizabeth S Danka; Aline B Scandurro
Journal:  Stem Cells       Date:  2007-10-04       Impact factor: 6.277

Review 2.  TLR8: an innate immune receptor in brain, neurons and axons.

Authors:  Yinghua Ma; Robin L Haynes; Richard L Sidman; Timothy Vartanian
Journal:  Cell Cycle       Date:  2007-09-04       Impact factor: 4.534

3.  Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment.

Authors:  Marie-Nicole Theodoraki; Saigopalakrishna Yerneni; Saumendra N Sarkar; Brian Orr; Ravikumar Muthuswamy; Jamie Voyten; Francesmary Modugno; Weijian Jiang; Melissa Grimm; Per H Basse; David L Bartlett; Robert P Edwards; Pawel Kalinski
Journal:  Cancer Res       Date:  2018-05-31       Impact factor: 12.701

4.  Toll in the vessel wall--for better or worse?

Authors:  Göran K Hansson; Anna M Lundberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-03       Impact factor: 11.205

5.  Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus.

Authors:  William E O'Gorman; Elena W Y Hsieh; Erica S Savig; Pier Federico Gherardini; Joseph D Hernandez; Leo Hansmann; Imelda M Balboni; Paul J Utz; Sean C Bendall; Wendy J Fantl; David B Lewis; Garry P Nolan; Mark M Davis
Journal:  J Allergy Clin Immunol       Date:  2015-05-30       Impact factor: 10.793

6.  STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

Authors:  Lekh N Dahal; Lang Dou; Khiyam Hussain; Rena Liu; Alexander Earley; Kerry L Cox; Salome Murinello; Ian Tracy; Francesco Forconi; Andrew J Steele; Patrick J Duriez; Diego Gomez-Nicola; Jessica L Teeling; Martin J Glennie; Mark S Cragg; Stephen A Beers
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

7.  Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Yali Wang; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

8.  Potentiation and tolerance of toll-like receptor priming in human endothelial cells.

Authors:  Stephen R Koch; Fred S Lamb; Judith Hellman; Edward R Sherwood; Ryan J Stark
Journal:  Transl Res       Date:  2016-08-08       Impact factor: 7.012

9.  Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

Authors:  Jing Zhou; Jun-O Jin; Juan Du; Qing Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

10.  It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection.

Authors:  Philberta Y Leung; Amy Eb Packard; Mary P Stenzel-Poore
Journal:  Future Neurol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.